SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-21-004184
Filing Date
2021-01-07
Accepted
2021-01-07 16:16:36
Documents
6

Document Format Files

Seq Description Document Type Size
1 S-3 d864611ds3.htm S-3 189122
2 EX-5.1 d864611dex51.htm EX-5.1 11756
3 EX-23.1 d864611dex231.htm EX-23.1 2451
4 GRAPHIC g864611g0106142143776.jpg GRAPHIC 1649
5 GRAPHIC g864611g02n32.jpg GRAPHIC 78757
6 GRAPHIC g864611g02n49.jpg GRAPHIC 75790
  Complete submission text file 0001193125-21-004184.txt   420004
Mailing Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140
Business Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140 617-744-1340
Syros Pharmaceuticals, Inc. (Filer) CIK: 0001556263 (see all company filings)

IRS No.: 453772460 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-251941 | Film No.: 21514387
SIC: 2834 Pharmaceutical Preparations